These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1327286

  • 1. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo.
    Landolfi R, Ciabattoni G, Patrignani P, Castellana MA, Pogliani E, Bizzi B, Patrono C.
    Blood; 1992 Oct 15; 80(8):1965-71. PubMed ID: 1327286
    [Abstract] [Full Text] [Related]

  • 2. Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
    Davì G, Averna M, Catalano I, Barbagallo C, Ganci A, Notarbartolo A, Ciabattoni G, Patrono C.
    Circulation; 1992 May 15; 85(5):1792-8. PubMed ID: 1572035
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
    Kumlin M, Dahlén B, Björck T, Zetterström O, Granström E, Dahlén SE.
    Am Rev Respir Dis; 1992 Jul 15; 146(1):96-103. PubMed ID: 1320824
    [Abstract] [Full Text] [Related]

  • 5. Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation.
    Petrucci G, Giaretta A, Ranalli P, Cavalca V, Dragani A, Porro B, Hatem D, Habib A, Tremoli E, Patrono C, Rocca B.
    Clin Transl Sci; 2022 Dec 15; 15(12):2958-2970. PubMed ID: 36200184
    [Abstract] [Full Text] [Related]

  • 6. Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo".
    Landolfi R, De Candia E, Rocca B, Ciabattoni G, Antinori A, Masetti R, Patrono C.
    Thromb Haemost; 1994 Dec 15; 72(6):942-6. PubMed ID: 7740468
    [Abstract] [Full Text] [Related]

  • 7. Paired analysis of urinary thromboxane B2 metabolites in humans.
    Catella F, FitzGerald GA.
    Thromb Res; 1987 Sep 15; 47(6):647-56. PubMed ID: 3686481
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
    Saloheimo P, Juvela S, Riutta A, Pyhtinen J, Hillbom M.
    Thromb Res; 2005 Sep 15; 115(5):367-73. PubMed ID: 15733969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
    DeFilippis AP, Oloyede OS, Andrikopoulou E, Saenger AK, Palachuvattil JM, Fasoro YA, Guallar E, Blumenthal RS, Kickler TS, Jaffe AS, Gerstenblith G, Schulman SP, Rade JJ.
    Circ J; 2013 Sep 15; 77(11):2786-92. PubMed ID: 23985963
    [Abstract] [Full Text] [Related]

  • 13. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.
    Davì G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C.
    Circulation; 1997 Jul 01; 96(1):69-75. PubMed ID: 9236419
    [Abstract] [Full Text] [Related]

  • 14. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
    Patrignani P, Morton H, Cirino M, Lord A, Charette L, Gillard J, Rokach J, Patrono C.
    Biochim Biophys Acta; 1989 Jul 21; 992(1):71-7. PubMed ID: 2752041
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C, Rivoltella L, Martelli L, Valzacchi S, Fanelli R.
    Biochim Biophys Acta; 1992 Feb 03; 1133(3):247-54. PubMed ID: 1737057
    [Abstract] [Full Text] [Related]

  • 17. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty.
    Ciabattoni G, Ujang S, Sritara P, Andreotti F, Davies G, Simonetti BM, Patrono C, Maseri A.
    J Am Coll Cardiol; 1993 May 03; 21(6):1377-81. PubMed ID: 8473644
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
    Cangemi R, Carnevale R, Nocella C, Calvieri C, Cammisotto V, Novo M, Castellani V, D'Amico A, Zerbinati C, Stefanini L, Violi F, SIXTUS Study Group.
    Pharmacol Res; 2018 May 03; 131():66-74. PubMed ID: 29577968
    [Abstract] [Full Text] [Related]

  • 20. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
    Davì G, Basili S, Vieri M, Cipollone F, Santarone S, Alessandri C, Gazzaniga P, Cordova C, Violi F.
    Am J Respir Crit Care Med; 1997 Dec 03; 156(6):1794-9. PubMed ID: 9412557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.